Dilevalol

This classification denotes a vasodilating agent and adrenergic antagonist with the molecular formula C19H24N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P6629XE33T, chemically known as (r,r)-labetalol but generally known as dilevalol, which bears US NIH Compound Identifier 134044. European Medicines Agency schedules Dilevalol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07145MIG. The term DILEVALOL is an International Non-Proprietary Name. DILEVALOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dilevalol under HS 29242995 and SITC 51479. As of Q4 2014, DILEVALOL remains the US FDA Preferred Term for this commodity. Dilevalol bears US NLM identifiers UMLS ID C0012368 and NCI Concept Code C65390. SMILES: OC(CNC(CCc1ccccc1)C)c1cc(c(O)cc1)C(=O)N.